Circle Slides After Compass Point Downgrades to Sell on Margin Squeeze

The Downgrade

Compass Point cut Circle from Neutral to Sell and lowered its price target from $79 to $77 — implying roughly 18% additional downside from the pre-move price of ~$94. The thesis is straightforward: USDC supply is migrating into lower-margin distribution channels, and the firm expects gross margins to compress through H1 2026.

This isn't Compass Point's first bearish call on Circle. They previously downgraded CRCL to Sell in July 2025 at $130, citing competition from banks entering stablecoins post-GENIUS Act. That call was early but directionally correct — the stock is now trading 30% below that level. The new $77 target reflects a grind lower in expectations rather than a single catalyst.

The core problem: Circle's gross profit margin sits at 8.67% on a trailing twelve-month basis. Revenue-sharing arrangements with distribution partners like Coinbase eat into interest income, and as USDC flows into institutional channels with negotiated rates, the take rate compresses further. Compass Point's 2027 EBITDA estimate sits 20% below Street consensus — if they're right, the current 40x forward EBITDA multiple has significant room to contract.

The Insider Selling Pattern

The downgrade didn't arrive in a vacuum. Circle insiders have been steadily offloading stock throughout the first week of April:

• Director Patrick Sean Neville sold 30,000 shares on April 1 at $98.04, totaling $2.94 million — the largest single transaction
• CFO Jeremy Fox-Geen sold 4,238 shares on April 2 at $90.00
• CAO Tamara Schulz sold 1,194 shares on April 2 at $87.58
• Director Burns M. Michele sold 1,666 shares on April 6 at ~$92.38
• Director Rajeev Date exercised options and sold 1,273 shares on April 7 at $95.00

Most were executed under pre-arranged 10b5-1 plans, which limits the signal value. But the clustering of sales across five separate insiders in a single week — while the stock was already in a downtrend from $130 — is the kind of pattern traders notice.

USDC Supply: Growth Story or Margin Trap

Circle posted $2.7 billion in revenue for 2025 as USDC supply surged to roughly $78 billion by the end of Q1 2026 — 220% growth since Q4 2023. On the surface, the growth story looks intact. But the supply has since pulled back to around $75 billion, and 95.5% of Circle's revenue comes from interest income on USDC reserves.

That concentration creates a double vulnerability. First, any USDC supply decline directly hits the top line. Second, the CLARITY Act — still working through Congress with a potential stablecoin yield ban — threatens the distribution economics that drive USDC adoption in the first place. Citi has argued the restrictions can "slow but not stop" USDC, but slowing growth on a stock priced for acceleration is its own kind of problem.

Meanwhile, the competitive landscape is tightening. Traditional banks and fintechs have signaled stablecoin ambitions post-GENIUS Act, and these entrants bring distribution networks Circle can't match without giving up more margin through revenue-sharing. Compass Point's thesis is essentially that Circle is caught in a margin trap: it needs to share more economics to grow supply, but sharing more economics destroys the profitability that justifies the valuation.

What to Watch

The near-term setup hinges on two things. First, whether USDC supply stabilizes or continues leaking from $78 billion. Circle's cirBTC launch — a 1:1 BTC-backed wrapped token announced April 2 — is an attempt to diversify beyond pure stablecoin economics, but it's pre-revenue and going up against entrenched competitors in cbBTC and WBTC.

Second, the CLARITY Act timeline. Senate Banking markup was pushed to late April after recess, and the yield ban language remains unchanged. If it passes with the ban intact, USDC's retail distribution channel takes a structural hit. Baird's $138 target and the Street consensus represent the bull case — that supply reaccelerates and margins hold. Compass Point's $77 is the bear case: margins compress, supply stagnates, and the 40x EBITDA multiple unwinds. At $93, the stock is pricing in something closer to the middle.

Trading on Hyperliquid

Trade CRCL on Hyperliquid with up to 10x leverage.